Atomic AI Launches with $35 Million Series A Financing to Advance AI-driven RNA Structure Platform for Treating Undruggable Diseases (January 25, 2023) | By BUSINESS WIRE. SAN FRANCISCO — (BUSINESS WIRE) — Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, launched today with a $35
By Ross Youngs, January 18, 2023. TOP 50 Microbiome posts out of hundreds of posts as rated by Impressions 1,300,000 + Impressions on LinkedIn The impression created a ranking of Ross’ Microbiome Posts on LinkedIn’s TOP 50 ~ 2022 review. Learn More
What’s in store for biotech in 2023? Perhaps 2022 will best be remembered in the life science industry for the return of many of the face-to-face events that fell by the wayside during the COVID-19 pandemic.
BIOHM Raises $7.5 Million to Accelerate Microbiome Research, Artificial Intelligence Capabilities and Product Development (January 12, 2023) | By BIOHM Health. The funding round, led by Middleland Capital’s VTC Ventures, will fast-track growth of A.I. technology and targeted, data-driven microbiome formulations CLEVELAND, Jan. 12, 2023 /PRNewswire/ — BIOHM, a leading microbiome company guided by the
Battelle, AmplifyBio, Andelyn team up NIH contract targeting stroke, neurological disease (January 10, 2023) | By Carrie Ghose – Staff reporter. A team comprising Battelle and two Central Ohio biotech startups has won a federal contract to supply the critical scientific and manufacturing support to bring regenerative medicine therapies for neurological disorders to market. Battelle
Biosortia Microbiomics to Present at Biotech Showcase™ 2023 Biosortia’s proven technology obtains nature’s previously inaccessible drug-like small molecules for treatments and cures
